By Michele Maatouk
Date: Tuesday 16 May 2023
(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.
By Michele Maatouk
Date: Monday 12 Dec 2022
(Sharecast News) - California-based biopharmaceutical group Amgen has agreed to buy Horizon Therapeutics in a $28.3bn deal.
By Abigail Townsend
Date: Tuesday 27 Sep 2022
(Sharecast News) - AstraZeneca drug Tezspire has been approved for use with patients with severe asthma in Japan, the blue chip confirmed on Tuesday.
Currency | US Dollars |
Share Price | $ 298.62 |
Change Today | $ 0.12 |
% Change | 0.04 % |
52 Week High | $324.56 |
52 Week Low | $218.65 |
Volume | 1,713,616 |
Shares Issued | 535.40m |
Market Cap | $159,881m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 8 |
Neutral | 13 |
Sell | 1 |
Strong Sell | 1 |
Total | 29 |
Time | Volume / Share Price |
15:59 | 100 @ $298.63 |
15:59 | 104 @ $298.66 |
15:59 | 100 @ $298.54 |
15:59 | 149 @ $298.55 |
15:59 | 134 @ $298.57 |
You are here: research